The Environmental Protection Agency (EPA) has shifted its approach to regulating pollutants, now focusing solely on the costs to businesses rather than factoring in the human lives saved by stricter standards. This marks a significant change in decades of practice, effectively assigning a value of $0 to human life in cost-benefit analyses concerning fine particulate matter (PM2.5) and ozone pollution.
New Policy Prioritizes Business Costs
Internal documents, as reported by The New York Times, reveal the EPA will no longer monetize the benefits of reducing PM2.5 and ozone – two air pollutants linked to lifelong respiratory issues and tens of thousands of premature deaths annually in the U.S. An email from an EPA supervisor and a recently posted agency rule cite “uncertainties” associated with quantifying the health impacts of these pollutants as justification for the change.
EPA spokesperson Carolyn Holran confirmed the shift, stating that “not monetizing does not equal not considering or not valuing the human health impact.” However, the change effectively removes a key metric previously used to justify pollution controls. In 2024, the EPA tightened restrictions on PM2.5, estimating it would prevent up to 4,500 premature deaths and 290,000 lost workdays by 2032, yielding $77 in health benefits for every $1 spent.
Implications for Future Regulations
This policy change is expected to make it easier to roll back existing pollution rules, particularly for facilities like coal-burning power plants and oil refineries. Internal communications suggest a deliberate pivot away from prioritizing environmental and public health protection toward a focus on aiding business interests. Aaron Szabo, head of the EPA’s air and radiation office, is a former lobbyist for the oil and chemical industries, a fact noted by the Times.
Patrick Drupp, policy director for the Sierra Club, called the change a “complete betrayal of the EPA’s mission,” stating that the agency under the current administration “has no interest in actually protecting American lives” and is focused on “protect[ing] the profits of fossil fuel companies.”
The move aligns with a broader trend of the administration sidelining public health in favor of decisions that prioritize profits, as evidenced by recent rollbacks to meat industry standards.
Frequently Asked Questions
What pollutants are affected by this change?
The EPA will no longer monetize the benefits of reducing fine particulate matter (PM2.5) and ozone pollution when assessing the costs and benefits of regulations.
What was the EPA’s previous practice?
For decades, the EPA had assigned a monetary value to human life and considered the economic impact of illness and death when evaluating pollution regulations.
What does the EPA say about valuing human health despite this change?
EPA spokesperson Carolyn Holran stated that “not monetizing does not equal not considering or not valuing the human health impact.”
How might this change affect communities living near industrial facilities?
Worth a look